Clinical Trial Supply and Logistics Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 4.29 Bn

Forecast Year, 2035

USD 8.95 Bn

CAGR, 2026 - 2035

7.63%

Report Coverage

Global

What is the Clinical Trial Supply And Logistics Market Size?

The global clinical trial supply and logistics market size is valued at USD 4.29 billion in 2025 and is predicted to increase from USD 4.63 billion in 2026 to approximately USD 8.95 billion by 2035, expanding at a CAGR of 7.63% from 2026 to 2035.

Clinical Trial Supply and Logistics Market Key Takeaways

• In terms of revenue, the global clinical trial supply and logistics market was valued at USD 4.29billion in 2025.
• It is projected to reach USD 8.95billion by 2035.
• The market is expected to grow at a CAGR of 7.63% from 2026 to 2035.
• North America dominated the global market with the largest market share of 36% in 2025.
• By service, the logistics & distribution segment captured the biggest market share of 28% in 2025.
• By service, the manufacturing segment is projected to grow at a significant CAGR from 2026 through 2035.
• By phase, Phase 3 contributed the highest market share of 40.41% in 2025.
• By phase, Phase 2 is expected to experience the fastest CAGR between 2026 and 2035.
• By therapeutic area, the cardiovascular diseases segment held the largest market share of 32.33% in 2025
• By therapeutic area, the rare diseases and orphan indications segment is expected to witness significant growth from 2026 to 2035.
• By end user, the pharmaceuticals segment generated the major market share of 42% in 2025

Market Overview

Clinical trial supply & logistics refers to the planning, management, and execution of the procurement, storage, distribution, and tracking of pharmaceutical products, medical devices, and other materials needed for clinical trials. Clinical trials are essential for evaluating the safety and efficacy of new drugs, therapies, and medical interventions before they can be approved for widespread use. Managing the supply chain and logistics for clinical trials is a critical aspect of ensuring that these trials are conducted efficiently and effectively.

Clinical Trial Supply and Logistics Market Growth Factors

The global clinical trial supply and logistics market involves sourcing and acquiring the necessary investigational products, placebos, comparators, and other materials required for the clinical trial. These materials are often provided by pharmaceutical companies or contract research organizations.

The clinical trial supply & logistics market is being driven by several factors, including a growing number of clinical trials, stringent regulatory requirements, advancements in technology, a rise in rare disease research, and growing mergers and acquisitions.

Market Scope

Market Dynamics

Driver

One of the strongest drivers to the market is the increasing complexity of clinical trials. Modern drug development often involves biologics, advanced therapies such as CAR-T, and precision medicines tailored to narrow patient populations. These therapies require strict temperature control, specialized packaging, and real time monitoring throughout distribution. As trials expand across multiple geographies to reach rare disease patients or diverse cohorts, supply chains must become more adaptive and resilient. This complexity is fuelling demand for logistics partners with advanced cold chain capabilities, digital tracking solutions, and global distribution networks that can ensure regulatory compliance and product integrity.

Another key driver is the globalization of clinical research. Pharmaceutical and biotechnology companies are increasingly conducting trials in emerging markets to access larger patient pools, speed up recruitment, and reduce overall development costs. This geographic spread creates challenges in coordinating shipments, adhering to varied regulatory frameworks, and maintaining quality standards across continents. To meet these needs, specialized logistics providers are investing in regional hubs, digital coordination platforms, and standardized operating procedures. The expansion of trials into Asia Pacific, Latin America, and Eastern Europe is therefore creating sustained demand for efficient and scalable supply solutions, significantly boosting market growth.

Restraint

A significant restraint for the market is the high cost of building and maintaining advanced cold chain logistics systems. Many investigational drugs, specially biologics and cell based therapies, require storage at ultra-low or cryogenic temperatures throughout transportation and storage. Establishing this infrastructure involves investment in specialized freezers, insulated packaging, backup power systems, and monitoring technologies, all of which significantly increase operational expenses. Smaller logistics providers and trial sponsors often struggle to meet these requirements, creating barriers to entry and slowing broader market participation.

Another major obstacle is the complex and fragmented regulatory environment across different countries and regions. Clinical trial supplies must comply with strict standards for labelling, documentation, import/export clearances, and handling procedures. Inconsistent regulations and lengthy approval timelines can delay shipments and disrupt trial schedules, particularly in global, multi-site studies. Non-compliance risks not only financial penalties but also jeopardise the validity of trial results. Navigating this regulatory patchwork requires significant expertise and resources, making it a persistent challenge for both sponsors and logistics providers.

Opportunity

Increasing collaborations

The increasing collaboration among the key market players is expected to offer a lucrative opportunity for market growth during the forecast period. For instance, in April 2022, Thermo Fisher Scientific Inc and Matrix clinical trials, a service of Matrix medical network, announced that they are working together to develop an innovative decentralized clinical trial (DCT) solution to deliver clinical trials to patients. To help in detecting, retaining, and attracting trial participants while guaranteeing a favorable patient experience, the company is deploying cutting-edge Matrix mobile research sites around the United States. The two businesses are simultaneously looking for ways to extend their partnership to new regions.

Service Insights

Within the service category, the manufacturing segment is emerging as the fastest-growing area of the clinical trial supply and logistics market. As clinical research becomes more complex and therapies increasingly shift toward personalized medicine, advanced biologics, and cell and gene therapies, the demand for specialized manufacturing capabilities is rising.

This includes not only the production of investigational drugs but also the preparation of highly sensitive formulations that require strict handling and quality control. The manufacturing segment is benefiting from growing outsourcing by pharmaceutical and biotechnology companies. Who rely on specialized partners to ensure efficiency, compliance, and scalability. This is creating sustained momentum positioning manufacturing as a critical growth driver in the years ahead.

Clinical Trial Supply And Logistics Market Revenue, By Service, 2023-2025 (USD Million)

Phase Insights

Among clinical trial phases, Phase 2 is expected to register the fastest growth over the forecast period. Early stage trails are expanding due to the surge in novel therapies, rare disease treatments, and targeted drug candidates entering the development pipeline. Sponsors are prioritizing rapid proof of concept studies to evaluate safety and tolerability before moving to later phases. With the global push to accelerate drug discovery, Phase 2 trials are seeing increased demand for agile and adaptive supply chains that can quickly respond to evolving trial designs. The need for specialized packaging, precise dosing, and smaller but highly customized supply volumes further strengthens the role of logistics partners in this segment, making Phase 2 a hotbed for growth within the market.

Clinical Trial Supply And Logistics Market Revenue, By Phase, 2023-2025 (USD Million)

End User Insights

In terms of end users, the biologicals segment is projected to experience the fastest expansion. The growing pipeline of biologics, including monoclonal antibodies, vaccines, and cell and gene therapies is driving demand for highly specialized clinical trial supply and logistics solutions. Unlike conventional pharmaceuticals, biologics often require ultra-low temperature storage, secure distribution channels, and advanced tracking technologies to maintain product integrity.

As investment in biologics intensifies across both established and emerging markets, clinical trial supply chains are adapting to manage the complexity and sensitivity of these products. This shift is pushing the biologicals segment to the forefront of market growth, as sponsors increasingly rely on logistics partners with deep expertise in biologic handling.

Clinical Trial Supply And Logistics Market Revenue, By End User, 2023-2025 (USD Million)

Therapeutic Area Insights

From a therapeutic standpoint, rare diseases and orphan indications are positioned as the fastest growing area in clinical trial supply and logistics. Advances in genomics and precision medicine have spurred development of highly targeted therapies for conditions with limited or no existing treatment options. These trials often involve smaller patient populations spread across multiple geographies, making the supply chain highly complex and logistically demanding.

Tailored solutions are required to ensure timely and secure delivery of investigational products to dispread trial sites. Additionally, strong regulatory incentives and rising investment in orphan drug research are accelerating activity in this space. As a result, the rare disease segment is gaining prominence, fuelling rapid growth in the demand for specialized trial supply and logistics support.

Clinical Trial Supply And Logistics Market Revenue, By Therapeutic Area, 2023-2025 (USD Million)

U.S. Clinical Trial Supply and Logistics Market Size from 2026 to 2035

The U.S. clinical trial supply and logistics market size was valued at USD 1.54 billion in 2024 and is projected to surpass around USD 3.13 billion by 2035, expanding at a CAGR of 7.35% between 2026 and 2035.

North America is expected to dominate the market over the forecast period due to the pharmaceutical hub. North America, particularly the United States, is a global hub for pharmaceutical and biotechnology research and development. The region is home to numerous pharmaceutical companies, contract research organizations (CROs), and academic institutions conducting clinical trials. These entities rely on clinical trial supply & logistics providers to support their trials. Moreover, the stringent regulatory environment is another important factor that propels the market growth in the area.

North America, particularly the United States, is a global hub for pharmaceutical and biotechnology research and development. The region is home to numerous pharmaceutical companies, contract research organizations (CROs), and academic institutions conducting clinical trials. These entities rely on clinical trial supply & logistics providers to support their trials. Moreover, the stringent regulatory environment is another important factor that propels the market growth in the area.

The United States Food and Drug Administration (FDA) and Health Canada are stringent regulatory authorities overseeing clinical trials and drug approvals in the region. Compliance with their regulations is essential. Clinical trial supply & logistics providers in the area have expertise in navigating these regulatory frameworks and ensuring that trial materials meet compliance requirements. Thus, this is expected to drive the market growth in the region.

The United States Food and Drug Administration (FDA) and Health Canada are stringent regulatory authorities overseeing clinical trials and drug approvals in the region. Compliance with their regulations is essential. Clinical trial supply & logistics providers in the area have expertise in navigating these regulatory frameworks and ensuring that trial materials meet compliance requirements. Thus, this is expected to drive the market growth in the region.

Asia Pacific is expected to grow at the highest CAGR over the forecast period. The region has witnessed a surge in clinical trial activity, driven by factors such as large patient populations, diverse disease demographics, and cost advantages. Pharmaceutical companies and CROs are conducting an increasing number of trials in the region, leading to greater demand for clinical trial supply & logistics services. Thus, the aforementioned stats are expected to drive the market growth during the forecast period.

The region has witnessed a surge in clinical trial activity, driven by factors such as large patient populations, diverse disease demographics, and cost advantages. Pharmaceutical companies and CROs are conducting an increasing number of trials in the region, leading to greater demand for clinical trial supply & logistics services. Thus, the aforementioned stats are expected to drive the market growth during the forecast period.

China

China leads Asia Pacific growth with government support for both pharmaceutical innovation and the expansion of its clinical trial infrastructure. China's National Medical Products Administration (NMPA) has created streamlined approval pathways that have accelerated timelines for clinical trial initiation, while the expansion of biotechnology parks and advanced manufacturing facilities is having a positive effect on local sponsors and global sponsors alike. The increase in participation by Chinese companies within multi-national clinical programs creates a favorable market for less sophisticated labeling, packaging and distribution systems; however, the improvement of temperature controlled transport systems and the availability of digital tracking technologies improve reliability. Additionally, the increase in domestic pharmaceutical product (drugs) innovation will allow for greater integration between clinical trial supply chains and global competitiveness within the supply chain.

What Is Driving Europe's Growth?

Europe's Clinical Trial Supply and Logistics Market is growing due to its strong regulatory support for cross-border trials and the centralized oversight from the European Medicines Agency (EMA), which ensures harmonized procedures across its member nations. Growth in advanced therapy medicinal products means there is increased demand for specialized packaging and ultra-cold storage options. Sustainability is also playing a role, as there are new initiatives to reduce the amount of waste that is being generated from trial supplies, which encourages innovation in packaging. The shift toward decentralized trials throughout Western Europe and Central European countries is also driving growth in last-mile logistics, which will assist with patient engagement models.

Germany

Germany is the primary country leading the growth in this area because of its highly developed healthcare system and one of the largest pharmaceutical production bases in the world. The country has many multinational and specialty research trial sites, as well as a very efficient transportation system and high-quality standards, which aid in the safe movement of trial supplies across international borders. Growth in oncology and rare disease trials has led to an increase in the demand for customized packaging and temperature-controlled solutions. Germany's commitment to innovation in biologics and personalized medicine has aided the rapid growth of complex trial logistics capabilities. The use of integrated digital tracking and inventory systems has improved transparency and compliance within clinical supply chains.

What Contributes to the Emergence of Clinical Trial Supply And Logistics Market In Latin America?

The clinical trial supply and logistics market in Latin America is growing significantly with the rise of multinational clinical trials, more advanced healthcare systems, and affordable operational costs. The patient population is diverse, making it appealing for global sponsors. Governments have also increased their regulatory transparency to speed up the approval process for studies. The increase in demand for temperature-controlled distribution as a result of growth in clinical trials for vaccines and infectious diseases has also supported the growth of the CT supply & logistics market. Additionally, improvements in airport logistics hubs and regional warehouse facilities have helped to ensure smoother cross-border movement of supplies. An increase in collaboration between local research institutions and international pharmaceutical companies is further driving the expansion of clinical trials throughout the region.

Brazil

Brazil is positioned at the top of the region with its large network of research hospitals and the growth of the Brazilian pharmaceutical industry. The large patient population in Brazil is also beneficial for Phase III clinical trials. Investments in cold chain logistics and new packaging technology have provided the necessary reliability to the supply chain of clinical trials in Brazil. Further, the expansion of clinical trials focused on oncology and biosimilars is expected to drive the need for a structured approach to clinical trial supply & logistics management. With recent improvements in digital infrastructure, Brazil has the capabilities to improve tracking and inventory management of supplies for complex clinical programs.

Why Is Middle East & Africa Notably Growing?

Why the Clinical Trial Supply & Logistics Market is growing in MAE?

There are two main reasons why this market is growing governments are investing in health care and are modernizing their regulatory processes to attract international sponsors for clinical research, and because of the growing need for supply chain networks due to the increase in chronic disease studies that require clinical trial supplies to be distributed in a timely manner. In addition, an increase in the number of healthcare free zones (HCFZ) and medical research clusters in the MEA region is enhancing the ability of the region to conduct clinical trials. Improvements in air cargo connectivity and dedicated storage facilities for temperature-sensitive clinical trial materials are contributing to this growth. As the region collaborates more with multinational pharmaceutical companies, it is being established as a developing geographical region for clinical research.

UAE

The UAE is the leading country in the MEA region in terms of investment in the development of healthcare innovation and research infrastructure to support the development of the clinical trial supply and logistics market. The UAE supports structured clinical governance through its regulatory bodies, including but not limited to the Ministry of Health and Prevention. The logistics hubs and free trade zones located within the UAE facilitate the efficient importation and exportation of investigational products for clinical trials. The rapid growth of specialty care centers in the UAE is creating opportunities for regional participation in clinical trials. Digital health platforms enable improved visibility into supply chains and improved logistics coordination. As an added benefit of its geographic position located at the intersection of Europe and Asia, the UAE serves as a very important logistical route for multinational clinical programs.

Segments Covered in the Report

• Almac Group
• DHL
• Parexel
• Thermo Fisher Scientific (Patheon)
• Marken
• Piramal Pharma Solutions
• UDG Healthcare
• Catalent, Inc.
• FedEx
• Movianto
• Packaging Coordinators Inc.

Segments Covered in the Report

By Service

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By End-user

• Pharmaceuticals
• Biologicals
• Medical Device

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa